Beyond Air Inc (XAIR) - Total Liabilities
Based on the latest financial reports, Beyond Air Inc (XAIR) has total liabilities worth $29.18 Million USD as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check financial resilience of Beyond Air Inc to evaluate the company's liquid asset resilience ratio.
Beyond Air Inc - Total Liabilities Trend (2014–2026)
This chart illustrates how Beyond Air Inc's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see Beyond Air Inc asset portfolio.
Beyond Air Inc Competitors by Total Liabilities
The table below lists competitors of Beyond Air Inc ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Avira Resources Ltd
AU:AVW
|
Australia | AU$114.47K |
|
Falcon Oil & Gas Ltd.
LSE:FOG
|
UK | GBX21.44 Million |
|
Webac Holding AG
F:RKB
|
Germany | €337.00K |
|
Green Minerals AS
OL:GEM
|
Norway | Nkr477.00K |
|
Uscom Ltd
AU:UCM
|
Australia | AU$278.09K |
|
Sri Havisha Hospitality and Infrastructure Limited
NSE:HAVISHA
|
India | Rs524.68 Million |
|
Majedie Investments
LSE:MAJE
|
UK | GBX813.00K |
Liability Composition Analysis (2014–2026)
This chart breaks down Beyond Air Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See Beyond Air Inc (XAIR) net asset quality to measure how much of total assets are equity-financed.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 3.80 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 4.76 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.82 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Beyond Air Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Beyond Air Inc (2014–2026)
The table below shows the annual total liabilities of Beyond Air Inc from 2014 to 2026.
| Year | Total Liabilities | Change |
|---|---|---|
| 2026-03-31 | $29.18 Million | +85.58% |
| 2025-03-31 | $15.72 Million | -47.20% |
| 2024-03-31 | $29.77 Million | +11.43% |
| 2023-03-31 | $26.72 Million | +27.30% |
| 2022-03-31 | $20.99 Million | +108.61% |
| 2021-03-31 | $10.06 Million | +7.70% |
| 2020-03-31 | $9.34 Million | +72.90% |
| 2019-03-31 | $5.40 Million | -30.82% |
| 2018-03-31 | $7.81 Million | +25012.07% |
| 2017-03-31 | $31.10K | 0.00% |
| 2016-03-31 | $31.10K | -98.03% |
| 2015-03-31 | $1.58 Million | +271.29% |
| 2014-03-31 | $425.00K | -- |
About Beyond Air Inc
Beyond Air, Inc. operates as a commercial-stage medical device and biopharmaceutical company. It operates through Beyond Air, Beyond Cancer, and NeuroNos segments. The company offers Lungfit PH for the treatment of persistent pulmonary hypertension of the newborn. It is also developing LungFit PRO to treat viral lung infections, such as viral community-acquired pneumonia, including COVID-19 and b… Read more